Fabino Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve In continuation of our letter dated May 17, 2023, pursuant to regulation 33 read with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting scheduled to be held on 24th May, now stands adjourned due to non-availability of Directors and the meeting will now be held on Tuesday, May 30, 2023 at Registered Office of the Company at 105, Plot No 12, Barodia Tower, 1st Floor, D Block, Central Market, Prashant Vihar, New Delhi- 110085, inter-alia to discuss and approve, among other items, the Audited Financial Results and Statement of Assets and Liabilities for Half Year and Financial Year ended March 31, 2023